Cigna Group CI
272.01
6.51
2.45%
as of 25 Sep
- Market cap
- $69.9B
- P/E
- 11.3×
Follow CI
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cigna Group (CI) Return on equity
Cigna Group's return on equity over the twelve months to 30 June 2026 was 15.4%, up 1.1 percentage points from fiscal 2025 (14.3%). Over the past ten years it has ranged from 7.85% (fiscal 2024) to 18.3% (fiscal 2015); the current reading is higher than 55% of that period. That is above the Healthcare Plans industry median of 12.5% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 14.3% | 6.48 |
| FY2024 | 7.85% | (3.51) |
| FY2023 | 11.4% | (3.24) |
| FY2022 | 14.6% | 3.58 |
| FY2021 | 11.0% | (6.66) |
| FY2020 | 17.7% | 5.86 |
| FY2019 | 11.8% | 2.19 |
| FY2018 | 9.63% | (6.68) |
| FY2017 | 16.3% | 1.82 |
| FY2016 | 14.5% | (3.85) |
Against its own ten years
Low 7.85%
High 18.3%
Ten-year median
14.3%
Current reading's percentile
55
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 34.2% |
| CI Cigna Group | 15.4% |
| UNH UnitedHealth Group Incorporated compare | 13.8% |
| ELV Elevance Health, Inc. compare | 11.2% |
| HUM Humana Inc. compare | 6.81% |
| CVS CVS Health Corporation compare | 6.21% |
| MOH Molina Healthcare, Inc compare | −0.16% |
| CLOV Clover Health Investments, Corp. compare | −5.10% |
| CNC Centene Corporation compare | −20.4% |
| Healthcare Plans industry median | 12.5% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CI
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement